179 related articles for article (PubMed ID: 38565540)
41. Caloric restriction reverses high-fat diet-induced endothelial dysfunction and vascular superoxide production in C57Bl/6 mice.
Ketonen J; Pilvi T; Mervaala E
Heart Vessels; 2010 May; 25(3):254-62. PubMed ID: 20512454
[TBL] [Abstract][Full Text] [Related]
42. Transient cell-in-cell formation underlies tumor relapse and resistance to immunotherapy.
Gutwillig A; Santana-Magal N; Farhat-Younis L; Rasoulouniriana D; Madi A; Luxenburg C; Cohen J; Padmanabhan K; Shomron N; Shapira G; Gleiberman A; Parikh R; Levy C; Feinmesser M; Hershkovitz D; Zemser-Werner V; Zlotnik O; Kroon S; Hardt WD; Debets R; Reticker-Flynn NE; Rider P; Carmi Y
Elife; 2022 Sep; 11():. PubMed ID: 36124553
[TBL] [Abstract][Full Text] [Related]
43. Obesity increases inflammation and impairs lymphatic function in a mouse model of lymphedema.
Savetsky IL; Torrisi JS; Cuzzone DA; Ghanta S; Albano NJ; Gardenier JC; Joseph WJ; Mehrara BJ
Am J Physiol Heart Circ Physiol; 2014 Jul; 307(2):H165-72. PubMed ID: 24858842
[TBL] [Abstract][Full Text] [Related]
44. Downregulation of exosomal MHC-I promotes glioma cells escaping from systemic immunosurveillance.
Sun T; Li Y; Wu J; Cao Y; Yang Y; He Y; Huang W; Liu B; Yang W
Nanomedicine; 2022 Nov; 46():102605. PubMed ID: 36113830
[TBL] [Abstract][Full Text] [Related]
45. Immune checkpoint blockade reprograms systemic immune landscape and tumor microenvironment in obesity-associated breast cancer.
Pingili AK; Chaib M; Sipe LM; Miller EJ; Teng B; Sharma R; Yarbro JR; Asemota S; Al Abdallah Q; Mims TS; Marion TN; Daria D; Sekhri R; Hamilton AM; Troester MA; Jo H; Choi HY; Hayes DN; Cook KL; Narayanan R; Pierre JF; Makowski L
Cell Rep; 2021 Jun; 35(12):109285. PubMed ID: 34161764
[TBL] [Abstract][Full Text] [Related]
46. Visceral fat accumulation induced by a high-fat diet causes the atrophy of mesenteric lymph nodes in obese mice.
Kim CS; Lee SC; Kim YM; Kim BS; Choi HS; Kawada T; Kwon BS; Yu R
Obesity (Silver Spring); 2008 Jun; 16(6):1261-9. PubMed ID: 18369345
[TBL] [Abstract][Full Text] [Related]
47. Peripubertal-onset but not adult-onset obesity increases IGF-I and drives development of lean mass, which may lessen the metabolic impairment in adult obesity.
Cordoba-Chacon J; Gahete MD; Pozo-Salas AI; Moreno-Herrera A; Castaño JP; Kineman RD; Luque RM
Am J Physiol Endocrinol Metab; 2012 Nov; 303(9):E1151-7. PubMed ID: 22932784
[TBL] [Abstract][Full Text] [Related]
48. Weight Loss and/or Sulindac Mitigate Obesity-associated Transcriptome, Microbiome, and Protumor Effects in a Murine Model of Colon Cancer.
Bowers LW; Glenny EM; Punjala A; Lanman NA; Goldbaum A; Himbert C; Montgomery SA; Yang P; Roper J; Ulrich CM; Dannenberg AJ; Coleman MF; Hursting SD
Cancer Prev Res (Phila); 2022 Aug; 15(8):481-495. PubMed ID: 35653548
[TBL] [Abstract][Full Text] [Related]
49. Selective impairment in dendritic cell function and altered antigen-specific CD8+ T-cell responses in diet-induced obese mice infected with influenza virus.
Smith AG; Sheridan PA; Tseng RJ; Sheridan JF; Beck MA
Immunology; 2009 Feb; 126(2):268-79. PubMed ID: 18754811
[TBL] [Abstract][Full Text] [Related]
50. OMIC signatures to understand cancer immunosurveillance and immunoediting: Melanoma and immune cells interplay in immunotherapy.
León-Letelier RA; Bonifaz LC; Fuentes-Pananá EM
J Leukoc Biol; 2019 May; 105(5):915-933. PubMed ID: 30698862
[TBL] [Abstract][Full Text] [Related]
51. [Cytotoxic T lymphocytes: role in immunosurveillance and in immunotherapy].
Benchetrit F; Gazagne A; Adotevi O; Haicheur N; Godard B; Badoual C; Fridman WH; Tartour E
Bull Cancer; 2003; 90(8-9):677-85. PubMed ID: 14609756
[TBL] [Abstract][Full Text] [Related]
52. Alterations in the mammary gland and tumor microenvironment of formerly obese mice.
Kuziel G; Moore BN; Haugstad GP; Xiong Y; Williams AE; Arendt LM
BMC Cancer; 2023 Dec; 23(1):1183. PubMed ID: 38041006
[TBL] [Abstract][Full Text] [Related]
53. Reduced Number and Immune Dysfunction of CD4+ T Cells in Obesity Accelerate Colorectal Cancer Progression.
Yamada K; Saito M; Ando M; Abe T; Mukoyama T; Agawa K; Watanabe A; Takamura S; Fujita M; Urakawa N; Hasegawa H; Kanaji S; Matsuda T; Oshikiri T; Kakeji Y; Yamashita K
Cells; 2022 Dec; 12(1):. PubMed ID: 36611881
[TBL] [Abstract][Full Text] [Related]
54. Energy balance, physical activity, and cancer risk.
Fair AM; Montgomery K
Methods Mol Biol; 2009; 472():57-88. PubMed ID: 19107429
[TBL] [Abstract][Full Text] [Related]
55. Diet induced obesity has an influence on intrahepatic T cell responses.
Gaur P; Cebula M; Riehn M; Hillebrand U; Hauser H; Wirth D
Metabolism; 2017 Apr; 69():171-176. PubMed ID: 28285647
[TBL] [Abstract][Full Text] [Related]
56. Expression of tumour-specific antigens underlies cancer immunoediting.
DuPage M; Mazumdar C; Schmidt LM; Cheung AF; Jacks T
Nature; 2012 Feb; 482(7385):405-9. PubMed ID: 22318517
[TBL] [Abstract][Full Text] [Related]
57. Obesity and adipose tissue impact on T-cell response and cancer immune checkpoint blockade therapy.
Pasquarelli-do-Nascimento G; Machado SA; de Carvalho JMA; Magalhães KG
Immunother Adv; 2022; 2(1):ltac015. PubMed ID: 36033972
[TBL] [Abstract][Full Text] [Related]
58. CD4 and CD8 T lymphocyte interplay in controlling tumor growth.
Ostroumov D; Fekete-Drimusz N; Saborowski M; Kühnel F; Woller N
Cell Mol Life Sci; 2018 Feb; 75(4):689-713. PubMed ID: 29032503
[TBL] [Abstract][Full Text] [Related]
59. Obesity and CD8 T cell metabolism: Implications for anti-tumor immunity and cancer immunotherapy outcomes.
Turbitt WJ; Buchta Rosean C; Weber KS; Norian LA
Immunol Rev; 2020 May; 295(1):203-219. PubMed ID: 32157710
[TBL] [Abstract][Full Text] [Related]
60. Immunosurveillance and immunoediting--can the immune response be made more "immunodemocratic"?
Mincheff M
J BUON; 2009 Sep; 14 Suppl 1():S89-96. PubMed ID: 19785075
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
